Nektar TherapeuticsNKTRNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank14
3Y CAGR-44.5%
5Y CAGR-40.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-44.5%/yr
vs -18.0%/yr prior
5Y CAGR
-40.3%/yr
Recent deceleration
Acceleration
-26.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.12M | -65.8% |
| 2024 | $44.25M | +25.4% |
| 2023 | $35.28M | -60.0% |
| 2022 | $88.23M | +249.9% |
| 2021 | $25.22M | -87.3% |
| 2020 | $198.96M | +106.5% |
| 2019 | $96.36M | -50.6% |
| 2018 | $194.91M | +3992.9% |
| 2017 | $4.76M | -92.0% |
| 2016 | $59.64M | - |